ertugliflozin

Pfizer (NYSE: PFE) is down Tuesday after reporting woeful first-quarter earnings and lowering its guidance. The New York City-based firm's EPS rose 58 percent to $0.38, but fell far short of the $0.56 Wall Street consensus. Revenue fell over nine percent to $13.5 billion, missing the $14...